Reduces Cardiovascular Risk: The SELECT trial demonstrated that semaglutide 2.4 mg reduced the relative risk for major adverse cardiovascular events by 20% compared with placebo in adults with established cardiovascular disease and BMI 27 kg/m
' Provides antioxidant support for liver tissue health and protection'
Offering their weight-loss and diabetes medications directly to patients, similar to how the compounding companies were operating, is a marked departure from the norm and could have profound effects for patients, plan sponsors, and the broader healthcare system
Some animal studies, however, have raised concerns about growth and development issues in the offspring (14,15)
[PMC free article: PMC3437049] [PubMed: 22548251] 405
The best lip balm in the market place